CR8184A - Pirimidinas 2-sustituidas - Google Patents

Pirimidinas 2-sustituidas

Info

Publication number
CR8184A
CR8184A CR8184A CR8184A CR8184A CR 8184 A CR8184 A CR 8184A CR 8184 A CR8184 A CR 8184A CR 8184 A CR8184 A CR 8184A CR 8184 A CR8184 A CR 8184A
Authority
CR
Costa Rica
Prior art keywords
substituted pyrimidines
pyrimidines
substituted
refers
formula
Prior art date
Application number
CR8184A
Other languages
English (en)
Spanish (es)
Inventor
Tormo I Blasco Jordi
Schwogler Anja
Gewehr Markus
Muller Bernd
Grote Thomas
Grammenos Wassilios
Gypser Andreas
Rheinheimer Joachim
Blettner Carsten
Schafer Peter
Schieweck Frank
Wagner Oliver
Stierl Reinhard
Schofl Ulrich
Strathmann Siegfred
Scherer Maria
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CR8184A publication Critical patent/CR8184A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CR8184A 2003-07-24 2006-01-11 Pirimidinas 2-sustituidas CR8184A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09

Publications (1)

Publication Number Publication Date
CR8184A true CR8184A (es) 2006-10-06

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8184A CR8184A (es) 2003-07-24 2006-01-11 Pirimidinas 2-sustituidas

Country Status (30)

Country Link
US (1) US7375108B2 (https=)
EP (1) EP1651618B1 (https=)
JP (1) JP2006528603A (https=)
KR (1) KR20060052857A (https=)
AP (1) AP2157A (https=)
AR (1) AR045100A1 (https=)
AT (1) ATE350370T1 (https=)
AU (1) AU2004261373B8 (https=)
BR (1) BRPI0412891A (https=)
CA (1) CA2532718A1 (https=)
CO (1) CO5660292A2 (https=)
CR (1) CR8184A (https=)
CY (1) CY1106391T1 (https=)
DE (1) DE502004002570D1 (https=)
DK (1) DK1651618T3 (https=)
EA (1) EA010566B1 (https=)
EC (1) ECSP066278A (https=)
ES (1) ES2279395T3 (https=)
HR (1) HRP20070057T3 (https=)
IL (1) IL172848A0 (https=)
MA (1) MA27949A1 (https=)
MX (1) MXPA06000038A (https=)
NZ (1) NZ545103A (https=)
PE (1) PE20050882A1 (https=)
PL (1) PL1651618T3 (https=)
PT (1) PT1651618E (https=)
SI (1) SI1651618T1 (https=)
TW (1) TW200516075A (https=)
UY (1) UY28436A1 (https=)
WO (1) WO2005012261A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1768972A1 (de) * 2004-07-14 2007-04-04 Basf Aktiengesellschaft 2-substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
BR112013011868A2 (pt) * 2010-11-16 2016-08-23 Acetylon Pharmaceuticals Inc compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
ES2929576T3 (es) 2013-10-08 2022-11-30 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
WO2015054474A1 (en) 2013-10-10 2015-04-16 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
US10660890B2 (en) 2013-10-24 2020-05-26 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) Treatment of polycystic diseases with an HDAC6 inhibitor
CR20160308A (es) 2013-12-03 2016-11-08 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
SG11201700094TA (en) 2014-07-07 2017-02-27 Acetylon Pharmaceuticals Inc Treatment of leukemia with histone deacetylase inhibitors
US9937174B2 (en) 2014-12-05 2018-04-10 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
EP3445364A4 (en) 2016-04-19 2019-11-27 Acetylon Pharmaceuticals, Inc. HDAC INHIBITORS, ONLY OR IN COMBINATION WITH BTK INHIBITORS, FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
JP6976577B2 (ja) * 2016-07-20 2021-12-08 国立大学法人東北大学 PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE303367T1 (de) 2000-06-13 2005-09-15 5 phenyl substituierte 2-(cyanoamino)-pyrimidine als fungizide
WO2002074753A2 (de) 2001-03-15 2002-09-26 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen
CA2467683C (en) 2001-11-19 2011-09-27 Basf Aktiengesellschaft 5-phenylpyrimidines, agents comprising the same, method for production and use thereof

Also Published As

Publication number Publication date
EA010566B1 (ru) 2008-10-30
PT1651618E (pt) 2007-03-30
ES2279395T3 (es) 2007-08-16
PE20050882A1 (es) 2005-12-01
MXPA06000038A (es) 2006-03-21
DE502004002570D1 (de) 2007-02-15
ATE350370T1 (de) 2007-01-15
NZ545103A (en) 2008-06-30
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
EP1651618A1 (de) 2006-05-03
AR045100A1 (es) 2005-10-12
WO2005012261A1 (de) 2005-02-10
CY1106391T1 (el) 2011-10-12
JP2006528603A (ja) 2006-12-21
AP2006003497A0 (en) 2006-02-28
TW200516075A (en) 2005-05-16
IL172848A0 (en) 2006-06-11
AP2157A (en) 2010-09-13
HRP20070057T3 (hr) 2007-07-31
SI1651618T1 (sl) 2007-06-30
US7375108B2 (en) 2008-05-20
AU2004261373A1 (en) 2005-02-10
CO5660292A2 (es) 2006-07-31
EP1651618B1 (de) 2007-01-03
PL1651618T3 (pl) 2007-05-31
CA2532718A1 (en) 2005-02-10
MA27949A1 (fr) 2006-06-01
UY28436A1 (es) 2005-02-28
BRPI0412891A (pt) 2006-10-03
KR20060052857A (ko) 2006-05-19
AU2004261373B2 (en) 2010-08-19
AU2004261373B8 (en) 2010-11-04
US20070105873A1 (en) 2007-05-10
ECSP066278A (es) 2006-07-28

Similar Documents

Publication Publication Date Title
PA8649401A1 (es) Analogos de anilino-pirimidina
CY1110933T1 (el) 5,7-διαμινοπυραζολο[4,3-d]πυριμιδινες με ανασταλτικη της pde-5 δραστικοτητα
CR8475A (es) Fenilalanina-amidas sustituidas por benzoilo
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
CR9947A (es) Compuestos de pirimidinil benzotiofeno
HN2005000477A (es) Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa
CY1115713T1 (el) Παραγωγα ακρυλαμιδιου ως αντιβιοτικοι παραγοντες
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CR8184A (es) Pirimidinas 2-sustituidas
ATE483000T1 (de) Naphtalin-amidin-imide
CY1109992T1 (el) Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα
BRPI0516242A (pt) compostos tieno-pirimidina tendo atividade fungicida
UY27250A1 (es) Fenil-heterociclil-cteres
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
BRPI0416678A (pt) pirazolpirimidinas
CR8185A (es) Pirimidinas 2- sustituidas
CR8334A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables
DE602004030231D1 (de) Pyrimidinonverbindungen als calcilytica
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
CR9578A (es) Inhibidores de la adenilato ciclasa soluble
DK1893597T3 (da) AMPA-receptorpotentiatorer
CR9435A (es) Uso de un compuesto